Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Curaleaf Holdings ( (TSE:CURA) ) has issued an announcement.
Curaleaf Holdings reported a second-quarter 2025 revenue of $315 million, with a notable 62% year-over-year growth in its international segment. The company was awarded a license to operate in Turkey, marking a significant expansion in its international operations. Despite a net loss, Curaleaf is focusing on strategic growth, including opening new retail locations, launching innovative products, and strengthening its leadership team to position itself for future industry growth.
The most recent analyst rating on (TSE:CURA) stock is a Buy with a C$6.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.
Spark’s Take on TSE:CURA Stock
According to Spark, TipRanks’ AI Analyst, TSE:CURA is a Neutral.
Curaleaf Holdings’ stock score is driven by strong technical momentum and positive corporate events, offset by weak financial performance and valuation concerns. While international growth and strategic initiatives are promising, profitability and leverage risks remain significant challenges.
To see Spark’s full report on TSE:CURA stock, click here.
More about Curaleaf Holdings
Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, operating in 17 U.S. states and 15 countries worldwide. The company focuses on expanding its global footprint and enhancing product quality, customer service, and supply chain excellence to capitalize on the growing demand for cannabis.
Average Trading Volume: 314,525
Technical Sentiment Signal: Hold
Current Market Cap: C$2B
For a thorough assessment of CURA stock, go to TipRanks’ Stock Analysis page.